Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2023-07-26 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve Meeting of the Board of Directors ....
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. This matches the pattern of a regulatory filing or certification document rather than a full report or announcement. Therefore, it should be classified as a Regulatory Filing (RNS).
2023-07-26 English
Book Closure for 44th Annual General Meeting
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. Given the lack of content and the presence of a digital signature, this is likely an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2023-07-17 English
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. This matches the pattern of an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2023-07-17 English
Book Closure from 24th July 2023 to 1st August 2023
AGM Information Classification · 100% confidence The document is a detailed notice for the 44th Annual General Meeting (AGM) of Lyka Labs Limited, scheduled for August 2, 2023. It includes the agenda items such as adoption of audited financial statements for the year ended March 31, 2023, appointment of a director, approval of related party transactions, and remuneration to the cost auditor. It also contains procedural instructions for e-voting, participation via video conferencing, and other administrative details related to the AGM. The document does not contain the actual financial statements or detailed financial analysis but is a formal notice calling the AGM and outlining the business to be transacted. Therefore, it fits the category of AGM Information (AGM-R) rather than the Annual Report or other financial filings.
2023-07-14 English
Record date fixed for 44th Annual General Meeting
AGM Information Classification · 95% confidence The document is a detailed notice for the 44th Annual General Meeting (AGM) of Lyka Labs Limited, scheduled for August 2, 2023. It includes agenda items such as adoption of audited financial statements for the year ended March 31, 2023, appointment of a director, approval of related party transactions, and remuneration to the cost auditor. It also contains procedural instructions for e-voting, participation via video conferencing, and other AGM logistics. The document is clearly a notice calling for the AGM and providing information about the meeting and voting process, rather than the actual annual report or financial statements themselves. Therefore, it fits the category of AGM Information (AGM-R).
2023-07-14 English
Pursuant to Reg 39(3) of the SEBI (LODR) Regulation 2015, the Company has received intimation from Link Intime India Private Limited (RTA) pertaining to loss of share certificates.
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. Given the lack of content and the presence of a digital signature, this is likely a regulatory filing or certification-type document without substantive report data. According to the rules, such documents should be classified as Regulatory Filings (RNS).
2023-07-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.